Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee

By afschroeder • February 27, 2026

Campochiaro C, Maltez N, Suliman Y, Alunno A, Alcacer-Pitarch B, Allanore Y, Baron M, Chung L, Del Galdo F, Denton CP, Distler O, Furst D, Galetti I, Giuggioli D, Khanna D, Krieg T, Moinzadeh P, Kuwana M, Matucci-Cerinic M, Pope J, Hughes M. Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee. Autoimmun Rev. 2026 Feb 23:104010. doi: 10.1016/j.autrev.2026.104010. Epub ahead of print. PMID: 41740914.

Tags: clinical trials, digital ulcers, outcome measures, patient-reported outcomes, Publications, Rheumatology, Standardization, systemic sclerosis, Wound Care

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial

Socinski MA, Stahel R, Lee DH, Cappuzzo F, Nishio M, Lovly CM, Ozyilkan O, Li Q, Johnson M, Garon EB, Kilickap S, Ferreira da Silva[...]

Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase in Aeromonas spp

von Bredow B, Trejo M, Ward KW, Trieu KP, Santellan CA, Garner OB, Yang S, Chandrasekaran S. Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase[...]

Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial

Budoff MJ, Verghese D, Kinninger A, Lakshmanan S. Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial. Eur Heart J Cardiovasc Imaging. 2026[...]